HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intravesical antitumor therapy immediately after transurethral resection of bladder cancer.

Abstract
Patients with superficial transitional cell cancer of the urinary bladder were entered into a randomized trial to compare the effects of immediate and short-term postoperative instillation of peplomycin sulfate with simple irrigation. Although the recurrence-free rate of the 46 peplomycin-treated patients was lower, the difference was not significant. Repeated washing of the bladder at the end of transurethral resection might partly replace the role of cytotoxic therapy.
AuthorsK Fujita
JournalInternational journal of urology : official journal of the Japanese Urological Association (Int J Urol) Vol. 1 Issue 4 Pg. 341-4 (Dec 1994) ISSN: 0919-8172 [Print] Australia
PMID7614398 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Peplomycin
Topics
  • Administration, Intravesical
  • Aged
  • Carcinoma, Transitional Cell (drug therapy)
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Peplomycin (administration & dosage, blood)
  • Recurrence
  • Therapeutic Irrigation
  • Time Factors
  • Tumor Cells, Cultured (drug effects)
  • Urinary Bladder Neoplasms (drug therapy, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: